Gossamer Bio (GOSS) Operating Margin (2024 - 2026)
Gossamer Bio (GOSS) posted quarterly Operating Margin of 264.62% for Q1 2026, up 10761.0% year-over-year from N/an in Q1 2025, and up 20.69% quarter-over-quarter from 333.64% in Q4 2025.
Gossamer Bio (GOSS) Operating Margin (2024 - 2026) Analysis & Trends
Gossamer Bio's Operating Margin history runs 3 years deep, the most recent figure standing at 264.62% for Q1 2026.
- In Q1 2026, Operating Margin rose 10761.0% year-over-year to 264.62%; the TTM figure through Mar 2026 stood at 321.92% (down 26747.0% YoY), while the FY2025 annual figure was 352.23%, down 28616.0% from the prior year.
- Operating Margin for Q1 2026 stood at 264.62%, up from 333.64% in the prior quarter.
- The five-year high for Operating Margin was 247.08% in Q4 2024, with the low at 372.23% in Q1 2025.
- The 3-year median for Operating Margin is 335.52% (2025), against an average of 216.71%.
- The sharpest annual moves came in 2025 and 2026: Operating Margin tumbled 58072 bps in 2025, then soared 10761 bps in 2026.
- Gossamer Bio's Operating Margin stood at 247.08% in 2024, then sank by 235 bps to 333.64% in 2025, then advanced by 21 bps to 264.62% in 2026.
- Business Quant data shows GOSS's Operating Margin at 264.62% in Q1 2026, 333.64% in Q4 2025, and 369.44% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | Gossamer Bio | 50.34 Mn | -6.69 Mn | - | -282.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -282.25% |
| Mar 31, 2026 | -264.62% |
| Dec 31, 2025 | -333.64% |
| Sep 30, 2025 | -369.44% |
| Jun 30, 2025 | -337.41% |
| Mar 31, 2025 | -372.23% |
| Dec 31, 2024 | 247.08% |
| Sep 30, 2024 | -357.80% |
| Jun 30, 2024 | 54.35% |